Ceramide lipid-based nanosuspension for enhanced delivery of docetaxel with synergistic antitumor efficiency

References

• Adkins SS, Hobbs HR, Benaissi K, et al. (2008). Stable colloidal dispersions of a lipase-perfluoropolyether complex in liquid and supercritical carbon dioxide. J Phys Chem B 112:4760–9
   PubMed Web of Science ®Google Scholar
• Aryal S, Hu CM, Zhang L. (2011). Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy. Mol Pharm 8:1401–7
   PubMed Web of Science ®Google Scholar
• Chi Le NU, Tabuchi K, Nakamagoe M, et al. (2015). Ceramide/sphingomyelin cycle involvement in gentamicin-induced cochlear hair cell death. Arch Toxicol 89:415–21
   PubMed Web of Science ®Google Scholar
• Cho HJ, Yoon HY, Koo H, et al. (2011). Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel. Biomaterials 32:7181–90
   PubMed Web of Science ®Google Scholar
• Choudhary GS, Al-Harbi S, Almasan A. (2015). Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol 1219:1–9
   PubMedGoogle Scholar
• Czubowicz K, Strosznajder R. (2014). Ceramide in the molecular mechanisms of neuronal cell death. The role of sphingosine-1-phosphate. Mol Neurobiol 50:26–37
   PubMed Web of Science ®Google Scholar
• Demetzos C, Pippa N. (2014). Advanced drug delivery nanosystems (aDDnSs): a mini-review. Drug Deliv 21:250–7
   PubMed Web of Science ®Google Scholar
• Duong HH, Yung LY. (2013). Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment. Int J Pharm 454:486–95
   PubMed Web of Science ®Google Scholar
• Feng LX, Li M, Liu YJ, et al. (2014). Synergistic enhancement of cancer therapy using a combination of ceramide and docetaxel. Int J Mol Sci 15:4201–20
   PubMed Web of Science ®Google Scholar
• Fleige E, Quadir MA, Haag R. (2012). Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv Drug Deliv Rev 64:866–84
   PubMed Web of Science ®Google Scholar
• Jager E, Jager A, Chytil P, et al. (2013). Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyester. J Control Release 165:153–61
   PubMed Web of Science ®Google Scholar
• Ji C, Yang B, Yang YL, et al. (2010). Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition. Oncogene 29:6557–68
   PubMed Web of Science ®Google Scholar
• Kemp JA, Shim MS, Heo CY, Kwon YJ. (2016). “Combo” nanomedicine: co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy. Adv Drug Deliv Rev 98:3–18
   PubMed Web of Science ®Google Scholar
• Kratz F, Warnecke A. (2012). Finding the optimal balance: challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems. J Control Release 164:221–35
   PubMed Web of Science ®Google Scholar
• Li F, Zhang N. (2015). Ceramide: therapeutic potential in combination therapy for cancer treatment. Curr Drug Metab 17:37–51
   PubMed Web of Science ®Google Scholar
• Li X, Becker KA, Zhang Y. (2010). Ceramide in redox signaling and cardiovascular diseases. Cell Physiol Biochem 26:41–8
   PubMed Web of Science ®Google Scholar
• Liu D, Liu Z, Wang L, et al. (2011). Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf B Biointerfaces 85:262–9
   PubMed Web of Science ®Google Scholar
• Liu F, Li M, Liu C, et al. (2014). Tumor-specific delivery and therapy by double-targeted DTX-CMCS-PEG-NGR conjugates. Pharm Res 31:475–88
   PubMed Web of Science ®Google Scholar
• Liu X, Ryland L, Yang J, et al. (2010). Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia. Blood 116:4192–201
   PubMed Web of Science ®Google Scholar
• Luo K, Li C, Li L, et al. (2012). Arginine functionalized peptide dendrimers as potential gene delivery vehicles. Biomaterials 33:4917–27
   PubMed Web of Science ®Google Scholar
• Ma YY, Mou XZ, Ding YH, et al. (2016). Delivery systems of ceramide in targeted cancer therapy: ceramide alone or in combination with other anti-tumor agents. Expert Opin Drug Deliv 13:1–10
   PubMed Web of Science ®Google Scholar
• Oh KT, Lee ES, Kim D, Bae YH. (2008). L-histidine-based pH-sensitive anticancer drug carrier micelle: reconstitution and brief evaluation of its systemic toxicity. Int J Pharm 358:177–83
   PubMed Web of Science ®Google Scholar
• Peters GJ, Van Der Wilt CL, Van Moorsel CJ, et al. (2000). Basis for effective combination cancer chemotherapy with antimetabolites. Pharmacol Ther 87:227–53
   PubMed Web of Science ®Google Scholar
• Selzner M, Bielawska A, Morse MA, et al. (2001). Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res 61:1233–40
   PubMed Web of Science ®Google Scholar
• Shukla P, Mathur V, Kumar A, et al. (2014). Nanoemulsion based concomitant delivery of curcumin and etoposide: impact on cross talk between prostate cancer cells and osteoblast during metastasis. J Biomed Nanotechnol 10:3381–91
   PubMed Web of Science ®Google Scholar
• Su X, Song H, Niu F, et al. (2015). Co-delivery of doxorubicin and PEGylated C16-ceramide by nanoliposomes for enhanced therapy against multidrug resistance. Nanomedicine (Lond) 10:2033–50
   PubMed Web of Science ®Google Scholar
• Sun W, Zhang N, Li A, et al. (2008). Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes. Int J Pharm 353:243–50
   PubMed Web of Science ®Google Scholar
• Tang J, Zhang L, Gao H, et al. (2016). Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity. Drug Deliv 23:1130–43
   PubMed Web of Science ®Google Scholar
• Tkaczuk KH. (2009). Review of the contemporary cytotoxic and biologic combinations available for the treatment of metastatic breast cancer. Clin Ther 31:2273–89
   PubMed Web of Science ®Google Scholar
• Vicent MJ, Duncan R. (2006). Polymer conjugates: nanosized medicines for treating cancer. Trends Biotechnol 24:39–47
   PubMed Web of Science ®Google Scholar
• Wang L, Li M, Zhang N. (2012). Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy. Int J Nanomed 7:3281–94
   PubMed Web of Science ®Google Scholar
• Wang L, Liu Z, Liu D, et al. (2011). Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity. Int J Pharm 413:194–201
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang H, Hao J, et al. (2016). Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect. Drug Deliv 23:1398–403
   PubMed Web of Science ®Google Scholar
• Yanasarn N, Sloat BR, Cui Z. (2009). Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel. Int J Pharm 379:174–80
   PubMed Web of Science ®Google Scholar
• Zhang J, Qian Z, Gu Y. (2009). In vivo anti-tumor efficacy of docetaxel-loaded thermally responsive nanohydrogel. Nanotechnology 20:325102
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang N. (2013). How nanotechnology can enhance docetaxel therapy. Int J Nanomed 8:2927–41
   PubMed Web of Science ®Google Scholar
• Zhang W, Li C, Shen C, et al. (2015). Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment. Drug Deliv 22:1–6
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen T. (2012). Targeting nanomaterials: future drugs for cancer chemotherapy. Int J Nanomedicine 7:5283–4
   PubMed Web of Science ®Google Scholar
• Zhu QY, Wang Z, Ji C, et al. (2011). C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and alpha-tubulin hyperacetylation both in vitro and in vivo. Cell Death Dis 2:e117
   PubMed Web of Science ®Google Scholar